CaRi-heart technology
Revolutionary new technology to assess the risk of a serious heart condition or heart attack – many years before anything happens.

Neurology
This consultant does not have any reviews at the moment.
Reviewed By
Dr Miriam Mattoscio is a Consultant Neurologist with a special interest in Multiple Sclerosis (MS) at Queen’s Hospital (Barking Havering and Redbridge University Hospitals Trust) and an Honorary Senior Clinical Lecturer at Imperial College London.
She received her medical degree from G.D’Annunzio University (Chieti, Italy) with Distinction, then completing her neurology training and graduating Magna Cum Laude. During the last year of her specialty training, she completed a visiting research program conducting a pilot clinical study in the field of Neuroimmunology at Imperial College London, supported by the ICL MS Clinical Trial Collaboration. She obtained a PhD in Clinical Neuroimmunology from Imperial College London, with her research on MS immunology and biology of Hematopoietic Stem Cells in MS supported by the Italian MS Society and the MRC.
She leads a number of clinical research studies as a Consultant Neurologist at Queen’s Hospital, also lecturing on MS Immunology to both ICL undergraduates and Master Students in Translational Neuroscience. She collaborates with several researchers at ICL, UCLH, Bart and the London, Fondazione St. Lucia in Rome and also the University of Verona, contributing to basic and translational research studies in the field of MS immunology.
She has served as member of several advisory boards on clinical research, clinical service improvement and medical education initiatives.
She is a member of the Scientific Committee of the Italian MS Foundation (FISM) and a Fellow of the American Academy of Neurology since February 2023. She is the service lead at her local NHS Trust.
Italian, English
MD, PhD, MRCP, FAAN
General Medical Council: 7019887
This consultant doesn't have any consultation fees information at the moment.
This consultant does not have any reviews at the moment.
Reviewed By